These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8389340)

  • 1. Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing.
    Gardiner HM; Freeman CP; Jesinger DK; Collins SA
    Int J Obes Relat Metab Disord; 1993 May; 17(5):301-5. PubMed ID: 8389340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa.
    Fichter MM; Leibl C; Krüger R; Rief W
    Pharmacopsychiatry; 1997 May; 30(3):85-92. PubMed ID: 9211569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology.
    Fichter MM; Krüger R; Rief W; Holland R; Döhne J
    J Clin Psychopharmacol; 1996 Feb; 16(1):9-18. PubMed ID: 8834413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa.
    Keel PK; Wolfe BE; Liddle RA; De Young KP; Jimerson DC
    Arch Gen Psychiatry; 2007 Sep; 64(9):1058-66. PubMed ID: 17768271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications of eating disorders].
    Szabó P; Túry F
    Orv Hetil; 1994 May; 135(20):1067-72. PubMed ID: 8052493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open trial of fluvoxamine in the treatment of bulimia nervosa.
    Ayuso-Gutierrez JL; Palazón M; Ayuso-Mateos JL
    Int J Eat Disord; 1994 Apr; 15(3):245-9. PubMed ID: 8199604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.
    Monteleone P; Fabrazzo M; Tortorella A; Martiadis V; Serritella C; Maj M
    Psychoneuroendocrinology; 2005 Apr; 30(3):243-50. PubMed ID: 15511598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emotional eating, alexithymia, and binge-eating disorder in obese women.
    Pinaquy S; Chabrol H; Simon C; Louvet JP; Barbe P
    Obes Res; 2003 Feb; 11(2):195-201. PubMed ID: 12582214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of bulimia among secondary school students in Casablanca].
    Ghazal N; Agoub M; Moussaoui D; Battas O
    Encephale; 2001; 27(4):338-42. PubMed ID: 11686055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of bulimia nervosa and binge eating disorder.
    Walsh BT; Devlin MJ
    Addict Behav; 1995; 20(6):757-64. PubMed ID: 8820528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eating disorders: a review of the literature with emphasis on medical complications and clinical nutrition.
    Patrick L
    Altern Med Rev; 2002 Jun; 7(3):184-202. PubMed ID: 12126461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Employment and effectiveness of the BITE questionnaire in screening for eating disorders].
    Resch M
    Orv Hetil; 2003 Nov; 144(46):2277-81. PubMed ID: 14702923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of adolescent eating disorders: findings from the Victorian Adolescent Health Cohort Study.
    Patton GC; Coffey C; Sawyer SM
    Eur Child Adolesc Psychiatry; 2003; 12 Suppl 1():I25-9. PubMed ID: 12567212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychoeducative ambulatory group in bulimia nervosa. Evaluation of a short-term approach].
    Fernández F; Sánchez I; Turón JV; Jiménez S; Alonso P; Vallejo J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):23-8. PubMed ID: 9549133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Definition and classification of eating disorders].
    Nakano K; Nakajima H
    Nihon Rinsho; 2001 Mar; 59(3):528-33. PubMed ID: 11268603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW; Rickels K; Sondheimer SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short questionnaire for detecting abnormal eating behavior (binge eating). Test results in 320 persons with normal weight and overweight/obesity].
    Wernze H; Rühl H
    Dtsch Med Wochenschr; 2007 Aug; 132(31-32):1613-8. PubMed ID: 17654413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessing various aspects of the motivation to eat that can affect food intake and body weight control].
    Bellisle F
    Encephale; 2009 Apr; 35(2):182-5. PubMed ID: 19393389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two forms of disordered eating in obesity: binge eating and night eating.
    Stunkard AJ; Allison KC
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):1-12. PubMed ID: 12532147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are anorexia nervosa and bulimia variants of affective disorders?
    Vandereycken W
    Acta Psychiatr Belg; 1987; 87(3):267-80. PubMed ID: 3314354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.